Ocrelizumab Interactions
There are 433 drugs known to interact with ocrelizumab, along with 4 disease interactions. Of the total drug interactions, 44 are major, 380 are moderate, and 9 are minor.
- View all 433 medications that may interact with ocrelizumab
- View ocrelizumab disease interactions (4)
Most frequently checked interactions
View interaction reports for ocrelizumab and the medicines listed below.
- Advil (ibuprofen)
- Ambien (zolpidem)
- Aubagio (teriflunomide)
- Avonex (interferon beta-1a)
- Betaseron (interferon beta-1b)
- Celexa (citalopram)
- Centrum Silver (multivitamin with minerals)
- Citracal + D (calcium / vitamin d)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- CoQ10 (ubiquinone)
- Curcumin 95 (turmeric)
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Keppra (levetiracetam)
- Klonopin (clonazepam)
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Paracetamol (acetaminophen)
- Provigil (modafinil)
- Prozac (fluoxetine)
- Restasis (cyclosporine ophthalmic)
- Tecfidera (dimethyl fumarate)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Wellbutrin XL (bupropion)
- Zoloft (sertraline)
Ocrelizumab disease interactions
There are 4 disease interactions with ocrelizumab which include:
Report options
QR code containing a link to this page
More about ocrelizumab
- ocrelizumab consumer information
- Compare alternatives
- Reviews (192)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
